Holdings
Superstring Capital Management LP
As of Sep 30, 2026, Superstring Capital Management LP reported 33 positions worth US$190M. Largest: Cogent Biosciences, Inc., Axsome Therapeutics, Inc. and Trevi Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cogent Biosciences, Inc. | 597K | US$19.1M | +254K | Sep 30, 2026 |
| Axsome Therapeutics, Inc. | 102K | US$18.9M | +48,569 | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 985K | US$14.1M | +461K | Sep 30, 2026 |
| Genmab A/S | 366K | US$13M | −64,938 | Sep 30, 2026 |
| Climb Bio, Inc. | 918K | US$10.5M | +397K | Sep 30, 2026 |
| Zai Lab Ltd. | 363K | US$9.55M | +207K | Sep 30, 2026 |
| Adlai Nortye Group Ltd. | 588K | US$9.41M | new | Sep 30, 2026 |
| Revolution Medicines, Inc. | 41,784 | US$8.58M | −9,269 | Sep 30, 2026 |
| Celldex Therapeutics, Inc. | 242K | US$7.86M | −45,090 | Sep 30, 2026 |
| Immunovant, Inc. | 222K | US$7.5M | +13,753 | Sep 30, 2026 |